Details for New Drug Application (NDA): 207872
✉ Email this page to a colleague
The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Summary for 207872
Tradename: | CELECOXIB |
Applicant: | Tianjin Tianyao |
Ingredient: | celecoxib |
Patents: | 0 |
Pharmacology for NDA: 207872
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 207872
Suppliers and Packaging for NDA: 207872
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CELECOXIB | celecoxib | CAPSULE;ORAL | 207872 | ANDA | EPIC PHARMA, LLC | 42806-720 | 42806-720-60 | 60 CAPSULE in 1 BOTTLE (42806-720-60) |
CELECOXIB | celecoxib | CAPSULE;ORAL | 207872 | ANDA | EPIC PHARMA, LLC | 42806-721 | 42806-721-01 | 100 CAPSULE in 1 BOTTLE (42806-721-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Feb 25, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Feb 25, 2020 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Feb 25, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription